|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
283 a.a.
|
 |
|
|
|
|
|
|
|
113 a.a.
|
 |
|
|
|
|
|
|
|
216 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transcription factor
|
 |
|
Title:
|
 |
Ikappabalpha/nf-kappab complex
|
|
Structure:
|
 |
Protein (nf-kappa-b p65 subunit). Chain: a. Fragment: n-terminal and dimerization domains. Synonym: p65. Engineered: yes. Protein (nf-kappa-b p50d subunit). Chain: c. Fragment: n-terminal and dimerization domains. Synonym: p50d.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562. Homo sapiens. Human. Organism_taxid: 9606. Gene: mad-3.
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.223
|
R-free:
|
0.277
|
|
|
Authors:
|
 |
T.Huxford,D.-B.Huang,S.Malek,G.Ghosh
|
Key ref:
|
 |
T.Huxford
et al.
(1998).
The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.
Cell,
95,
759-770.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
13-Nov-98
|
Release date:
|
12-Apr-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q04207
(TF65_MOUSE) -
Transcription factor p65
|
|
|
|
Seq: Struc:
|
 |
 |
 |
549 a.a.
283 a.a.
|
|
|
|
|
|
|
 |
 |
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
nucleus
|
1 term
|
 |
|
Biological process
|
regulation of transcription
|
2 terms
|
 |
|
Biochemical function
|
transcription factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Cell
95:759-770
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.
|
|
T.Huxford,
D.B.Huang,
S.Malek,
G.Ghosh.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
IkappaBalpha regulates the transcription factor NF-kappaB through the formation
of stable IkappaBalpha/NF-kappaB complexes. Prior to induction, IkappaBalpha
retains NF-kappaB in the cytoplasm until the NF-kappaB activation signal is
received. After activation, NF-kappaB is removed from gene promoters through
association with nuclear IkappaBalpha, restoring the preinduction state. The 2.3
A crystal structure of IkappaBalpha in complex with the NF-kappaB p50/p65
heterodimer reveals mechanisms of these inhibitory activities. The presence of
IkappaBalpha allows large en bloc movement of the NF-kappaB p65 subunit
amino-terminal domain. This conformational change induces allosteric inhibition
of NF-kappaB DNA binding. Amino acid residues immediately preceding the nuclear
localization signals of both NF-kappaB p50 and p65 subunits are tethered to the
IkappaBalpha amino-terminal ankyrin repeats, impeding NF-kappaB from nuclear
import machinery recognition.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. NF-κB p50/p65 Heterodimer in Its Open and Closed
Conformations(a) NF-κB p50/p65 heterodimer bound to κB DNA
target ([16]) exhibits its open conformation. Note that the
amino-terminal domain of p50 subunit is present in this
DNA-bound complex.(b) Stereoview of the p50/p65 heterodimer in
its DNA-bound open conformation (p50dd in blue, p50
amino-terminal domain not present, and p65RHR in cyan) and
IκBα-bound closed conformation (p50dd in green and p65RHR in
red) overlayed by superposition of the dimerization domains. The
p65 amino-terminal domain rotates 171° and translates 38
Å between the two conformations.
|
 |
Figure 5.
Figure 5. IκBα Interactions with the p65 Amino-Terminal
Domain and NLS Polypeptides(a) Residues from the sixth ankyrin
repeat of IκBα (in purple) contact side chains from the p65
amino-terminal domain (in red). Amino acid single letter codes
are used.(b) The interaction of the p65 NLS polypeptide
(skeleton) is shown with IκBα ankyrin repeats 1, 2, and 3
depicted as a molecular surface. The orientation is the same as
in Figure 2A.(c) Molecular surface representation of the p65
amino-terminal domain according to local electrostatic surface
potentials (blue, positive; red, negative). Skeleton
representation of the amino acids 268–288 (part of sixth
ankyrin repeat and PEST sequence) of IκBα contact the basic
patch (blue) of the p65 amino-terminal domain. Orientation is as
in Figure 2B. DNA-binding loops 2 and 3 are labeled L2 and L3,
respectively. This is only part of the extensive network of
interacting electrostatic surfaces formed between the
amino-terminal and dimerization domains of p65 and IκBα.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Cell
(1998,
95,
759-770)
copyright 1998.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Manavalan,
R.Govindaraj,
G.Lee,
and
S.Choi
(2011).
Molecular modeling-based evaluation of dual function of IκBζ ankyrin repeat domain in toll-like receptor signaling.
|
| |
J Mol Recognit, 24,
597-607.
|
 |
|
|
|
|
 |
C.Zheng,
Q.Yin,
and
H.Wu
(2011).
Structural studies of NF-κB signaling.
|
| |
Cell Res, 21,
183-195.
|
 |
|
|
|
|
 |
I.DeVries,
D.U.Ferreiro,
I.E.Sánchez,
and
E.A.Komives
(2011).
Folding kinetics of the cooperatively folded subdomain of the IκBα ankyrin repeat domain.
|
| |
J Mol Biol, 408,
163-176.
|
 |
|
|
|
|
 |
K.Y.Moon
(2011).
Acrolein, an I-κBα-independent downregulator of NF-κB activity, causes the decrease in nitric oxide production in human malignant keratinocytes.
|
| |
Arch Toxicol, 85,
499-504.
|
 |
|
|
|
|
 |
L.Chen,
Q.Meng,
W.Kao,
and
Y.Xia
(2011).
IκB Kinase β Regulates Epithelium Migration during Corneal Wound Healing.
|
| |
PLoS One, 6,
e16132.
|
 |
|
|
|
|
 |
L.Gu,
T.Tsuji,
M.A.Jarboui,
G.P.Yeo,
N.Sheehy,
W.W.Hall,
and
V.W.Gautier
(2011).
Intermolecular masking of the HIV-1 Rev NLS by the cellular protein HIC: novel insights into the regulation of Rev nuclear import.
|
| |
Retrovirology, 8,
17.
|
 |
|
|
|
|
 |
S.C.Sue,
V.Alverdi,
E.A.Komives,
and
H.J.Dyson
(2011).
Detection of a ternary complex of NF-kappaB and IkappaBalpha with DNA provides insights into how IkappaBalpha removes NF-kappaB from transcription sites.
|
| |
Proc Natl Acad Sci U S A, 108,
1367-1372.
|
 |
|
|
|
|
 |
S.M.Wuerzberger-Davis,
Y.Chen,
D.T.Yang,
J.D.Kearns,
P.W.Bates,
C.Lynch,
N.C.Ladell,
M.Yu,
A.Podd,
H.Zeng,
T.T.Huang,
R.Wen,
A.Hoffmann,
D.Wang,
and
S.Miyamoto
(2011).
Nuclear export of the NF-κB inhibitor IκBα is required for proper B cell and secondary lymphoid tissue formation.
|
| |
Immunity, 34,
188-200.
|
 |
|
|
|
|
 |
S.Miyamoto
(2011).
Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.
|
| |
Cell Res, 21,
116-130.
|
 |
|
|
|
|
 |
T.Valovka,
and
M.O.Hottiger
(2011).
p65 controls NF-κB activity by regulating cellular localization of IκBβ.
|
| |
Biochem J, 434,
253-263.
|
 |
|
|
|
|
 |
B.Manavalan,
S.Basith,
Y.M.Choi,
G.Lee,
and
S.Choi
(2010).
Structure-function relationship of cytoplasmic and nuclear IκB proteins: an in silico analysis.
|
| |
PLoS One, 5,
e15782.
|
 |
|
|
|
|
 |
D.U.Ferreiro,
and
E.A.Komives
(2010).
Molecular mechanisms of system control of NF-kappaB signaling by IkappaBalpha.
|
| |
Biochemistry, 49,
1560-1567.
|
 |
|
|
|
|
 |
K.Y.Moon
(2010).
N-nitroso-N-methylurea and N-nitroso-N-ethylurea induce upregulation of cellular NF-kappa B activity through protein kinase C-dependent pathway in human malignant keratinocytes.
|
| |
Arch Pharm Res, 33,
133-139.
|
 |
|
|
|
|
 |
M.Rusu,
and
S.Birmanns
(2010).
Evolutionary tabu search strategies for the simultaneous registration of multiple atomic structures in cryo-EM reconstructions.
|
| |
J Struct Biol, 170,
164-171.
|
 |
|
|
|
|
 |
A.Fath-Goodin,
J.A.Kroemer,
and
B.A.Webb
(2009).
The Campoletis sonorensis ichnovirus vankyrin protein P-vank-1 inhibits apoptosis in insect Sf9 cells.
|
| |
Insect Mol Biol, 18,
497-506.
|
 |
|
|
|
|
 |
A.Lake,
L.A.Shield,
P.Cordano,
D.T.Chui,
J.Osborne,
S.Crae,
K.S.Wilson,
S.Tosi,
S.J.Knight,
S.Gesk,
R.Siebert,
R.T.Hay,
and
R.F.Jarrett
(2009).
Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.
|
| |
Int J Cancer, 125,
1334-1342.
|
 |
|
|
|
|
 |
A.Oeckinghaus,
and
S.Ghosh
(2009).
The NF-kappaB family of transcription factors and its regulation.
|
| |
Cold Spring Harbor Perspect Biol, 1,
a000034.
|
 |
|
|
|
|
 |
B.A.Jordan,
and
M.R.Kreutz
(2009).
Nucleocytoplasmic protein shuttling: the direct route in synapse-to-nucleus signaling.
|
| |
Trends Neurosci, 32,
392-401.
|
 |
|
|
|
|
 |
C.F.Cervantes,
P.R.Markwick,
S.C.Sue,
J.A.McCammon,
H.J.Dyson,
and
E.A.Komives
(2009).
Functional dynamics of the folded ankyrin repeats of I kappa B alpha revealed by nuclear magnetic resonance.
|
| |
Biochemistry, 48,
8023-8031.
|
 |
|
|
|
|
 |
C.F.László,
and
S.Wu
(2009).
Old target new approach: an alternate NF-kappaB activation pathway via translation inhibition.
|
| |
Mol Cell Biochem, 328,
9.
|
 |
|
|
|
|
 |
F.Wan,
and
M.J.Lenardo
(2009).
Specification of DNA binding activity of NF-kappaB proteins.
|
| |
Cold Spring Harbor Perspect Biol, 1,
a000067.
|
 |
|
|
|
|
 |
J.C.Stroud,
A.Oltman,
A.Han,
D.L.Bates,
and
L.Chen
(2009).
Structural basis of HIV-1 activation by NF-kappaB--a higher-order complex of p50:RelA bound to the HIV-1 LTR.
|
| |
J Mol Biol, 393,
98.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Shant,
K.Cheng,
B.S.Marasa,
J.Y.Wang,
and
J.P.Raufman
(2009).
Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis.
|
| |
Exp Cell Res, 315,
432-450.
|
 |
|
|
|
|
 |
L.Liu,
T.Sakai,
N.H.Tran,
R.Mukai-Sakai,
R.Kaji,
and
K.Fukui
(2009).
Nucling interacts with nuclear factor-kappaB, regulating its cellular distribution.
|
| |
FEBS J, 276,
1459-1470.
|
 |
|
|
|
|
 |
N.Soto-Nieves,
I.Puga,
B.T.Abe,
S.Bandyopadhyay,
I.Baine,
A.Rao,
and
F.Macian
(2009).
Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance.
|
| |
J Exp Med, 206,
867-876.
|
 |
|
|
|
|
 |
R.Ahmad,
D.Raina,
M.D.Joshi,
T.Kawano,
J.Ren,
S.Kharbanda,
and
D.Kufe
(2009).
MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.
|
| |
Cancer Res, 69,
7013-7021.
|
 |
|
|
|
|
 |
S.Bergqvist,
V.Alverdi,
B.Mengel,
A.Hoffmann,
G.Ghosh,
and
E.A.Komives
(2009).
Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha.
|
| |
Proc Natl Acad Sci U S A, 106,
19328-19333.
|
 |
|
|
|
|
 |
S.C.Sue,
and
H.J.Dyson
(2009).
Interaction of the IkappaBalpha C-terminal PEST sequence with NF-kappaB: insights into the inhibition of NF-kappaB DNA binding by IkappaBalpha.
|
| |
J Mol Biol, 388,
824-838.
|
 |
|
|
|
|
 |
S.J.Chang,
J.C.Hsiao,
S.Sonnberg,
C.T.Chiang,
M.H.Yang,
D.L.Tzou,
A.A.Mercer,
and
W.Chang
(2009).
Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-kappaB activation by tumor necrosis factor alpha but is independent of its host range function.
|
| |
J Virol, 83,
4140-4152.
|
 |
|
|
|
|
 |
S.Maas,
and
W.M.Gommans
(2009).
Identification of a selective nuclear import signal in adenosine deaminases acting on RNA.
|
| |
Nucleic Acids Res, 37,
5822-5829.
|
 |
|
|
|
|
 |
T.Huxford,
and
G.Ghosh
(2009).
A structural guide to proteins of the NF-kappaB signaling module.
|
| |
Cold Spring Harbor Perspect Biol, 1,
a000075.
|
 |
|
|
|
|
 |
V.Ropars,
G.Despouy,
M.H.Stern,
S.Benichou,
C.Roumestand,
and
S.T.Arold
(2009).
The TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.
|
| |
PLoS One, 4,
e6567.
|
 |
|
|
|
|
 |
Y.Yang,
X.Wang,
C.A.Hawkins,
K.Chen,
J.Vaynberg,
X.Mao,
Y.Tu,
X.Zuo,
J.Wang,
Y.X.Wang,
C.Wu,
N.Tjandra,
and
J.Qin
(2009).
Structural Basis of Focal Adhesion Localization of LIM-only Adaptor PINCH by Integrin-linked Kinase.
|
| |
J Biol Chem, 284,
5836-5844.
|
 |
|
|
|
|
 |
B.L.Moss,
S.Gross,
S.T.Gammon,
A.Vinjamoori,
and
D.Piwnica-Worms
(2008).
Identification of a ligand-induced transient refractory period in nuclear factor-kappaB signaling.
|
| |
J Biol Chem, 283,
8687-8698.
|
 |
|
|
|
|
 |
E.Mathes,
E.L.O'Dea,
A.Hoffmann,
and
G.Ghosh
(2008).
NF-kappaB dictates the degradation pathway of IkappaBalpha.
|
| |
EMBO J, 27,
1357-1367.
|
 |
|
|
|
|
 |
J.A.Schmid,
and
A.Birbach
(2008).
IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
|
| |
Cytokine Growth Factor Rev, 19,
157-165.
|
 |
|
|
|
|
 |
M.D.Buzzelli,
M.Navaratnarajah,
T.Ahmed,
M.Nagarajan,
M.L.Shumate,
C.H.Lang,
and
R.N.Cooney
(2008).
Nuclear factor kappaB mediates the inhibitory effects of interleukin-1 on growth hormone-inducible gene expression.
|
| |
J Trauma, 64,
1427.
|
 |
|
|
|
|
 |
M.Gao,
and
J.Skolnick
(2008).
DBD-Hunter: a knowledge-based method for the prediction of DNA-protein interactions.
|
| |
Nucleic Acids Res, 36,
3978-3992.
|
 |
|
|
|
|
 |
N.Bakkar,
J.Wang,
K.J.Ladner,
H.Wang,
J.M.Dahlman,
M.Carathers,
S.Acharyya,
M.A.Rudnicki,
A.D.Hollenbach,
and
D.C.Guttridge
(2008).
IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.
|
| |
J Cell Biol, 180,
787-802.
|
 |
|
|
|
|
 |
R.S.Huang,
S.Duan,
E.O.Kistner,
W.K.Bleibel,
S.M.Delaney,
D.L.Fackenthal,
S.Das,
and
M.E.Dolan
(2008).
Genetic variants contributing to daunorubicin-induced cytotoxicity.
|
| |
Cancer Res, 68,
3161-3168.
|
 |
|
|
|
|
 |
S.Basak,
and
A.Hoffmann
(2008).
Crosstalk via the NF-kappaB signaling system.
|
| |
Cytokine Growth Factor Rev, 19,
187-197.
|
 |
|
|
|
|
 |
S.Bergqvist,
G.Ghosh,
and
E.A.Komives
(2008).
The IkappaBalpha/NF-kappaB complex has two hot spots, one at either end of the interface.
|
| |
Protein Sci, 17,
2051-2058.
|
 |
|
|
|
|
 |
S.C.Sue,
C.Cervantes,
E.A.Komives,
and
H.J.Dyson
(2008).
Transfer of flexibility between ankyrin repeats in IkappaB* upon formation of the NF-kappaB complex.
|
| |
J Mol Biol, 380,
917-931.
|
 |
|
|
|
|
 |
S.M.Truhlar,
E.Mathes,
C.F.Cervantes,
G.Ghosh,
and
E.A.Komives
(2008).
Pre-folding IkappaBalpha alters control of NF-kappaB signaling.
|
| |
J Mol Biol, 380,
67-82.
|
 |
|
|
|
|
 |
S.R.White,
B.M.Fischer,
B.A.Marroquin,
and
R.Stern
(2008).
Interleukin-1beta mediates human airway epithelial cell migration via NF-kappaB.
|
| |
Am J Physiol Lung Cell Mol Physiol, 295,
L1018-L1027.
|
 |
|
|
|
|
 |
T.Shin,
S.Kuboki,
and
A.B.Lentsch
(2008).
Roles of nuclear factor-kappaB in postischemic liver.
|
| |
Hepatol Res, 38,
429-440.
|
 |
|
|
|
|
 |
W.H.Yang,
S.Y.Park,
H.W.Nam,
d.o. .H.Kim,
J.G.Kang,
E.S.Kang,
Y.S.Kim,
H.C.Lee,
K.S.Kim,
and
J.W.Cho
(2008).
NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions.
|
| |
Proc Natl Acad Sci U S A, 105,
17345-17350.
|
 |
|
|
|
|
 |
D.U.Ferreiro,
C.F.Cervantes,
S.M.Truhlar,
S.S.Cho,
P.G.Wolynes,
and
E.A.Komives
(2007).
Stabilizing IkappaBalpha by "consensus" design.
|
| |
J Mol Biol, 365,
1201-1216.
|
 |
|
|
|
|
 |
F.Wang,
J.Hu,
P.Song,
and
W.Gong
(2007).
Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.
|
| |
Mol Biol Rep, 34,
249-260.
|
 |
|
|
|
|
 |
K.Hochrainer,
G.Racchumi,
and
J.Anrather
(2007).
Hypo-phosphorylation leads to nuclear retention of NF-kappaB p65 due to impaired IkappaBalpha gene synthesis.
|
| |
FEBS Lett, 581,
5493-5499.
|
 |
|
|
|
|
 |
L.J.Terry,
E.B.Shows,
and
S.R.Wente
(2007).
Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport.
|
| |
Science, 318,
1412-1416.
|
 |
|
|
|
|
 |
M.Sommerhalter,
Y.Zhang,
and
A.C.Rosenzweig
(2007).
Solution structure of the COMMD1 N-terminal domain.
|
| |
J Mol Biol, 365,
715-721.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.W.Quasney
(2007).
Genetic influences on severe lung injury: how many more genes?
|
| |
Crit Care Med, 35,
976-977.
|
 |
|
|
|
|
 |
N.Rouas-Freiss,
P.Moreau,
C.Menier,
J.LeMaoult,
and
E.D.Carosella
(2007).
Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.
|
| |
Semin Cancer Biol, 17,
413-421.
|
 |
|
|
|
|
 |
R.Zhai,
W.Zhou,
M.N.Gong,
B.T.Thompson,
L.Su,
C.Yu,
P.Kraft,
and
D.C.Christiani
(2007).
Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians.
|
| |
Crit Care Med, 35,
893-898.
|
 |
|
|
|
|
 |
V.A.Yakovlev,
I.J.Barani,
C.S.Rabender,
S.M.Black,
J.K.Leach,
P.R.Graves,
G.E.Kellogg,
and
R.B.Mikkelsen
(2007).
Tyrosine nitration of IkappaBalpha: a novel mechanism for NF-kappaB activation.
|
| |
Biochemistry, 46,
11671-11683.
|
 |
|
|
|
|
 |
Y.Chen,
H.H.Li,
J.Fu,
X.F.Wang,
Y.B.Ren,
L.W.Dong,
S.H.Tang,
S.Q.Liu,
M.C.Wu,
and
H.Y.Wang
(2007).
Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.
|
| |
Cell Res, 17,
1020-1029.
|
 |
|
|
|
|
 |
Z.H.Wu,
and
S.Miyamoto
(2007).
Many faces of NF-kappaB signaling induced by genotoxic stress.
|
| |
J Mol Med, 85,
1187-1202.
|
 |
|
|
|
|
 |
A.A.Khalil,
J.C.Hall,
F.A.Aziz,
and
P.Price
(2006).
Tumour necrosis factor: implications for surgical patients.
|
| |
ANZ J Surg, 76,
1010-1016.
|
 |
|
|
|
|
 |
G.Calvaruso,
M.Giuliano,
P.Portanova,
A.De Blasio,
R.Vento,
and
G.Tesoriere
(2006).
Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8.
|
| |
Mol Cell Biochem, 287,
13-19.
|
 |
|
|
|
|
 |
J.J.Wilson,
and
R.A.Kovall
(2006).
Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.
|
| |
Cell, 124,
985-996.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Yang,
K.I.Amiri,
J.R.Burke,
J.A.Schmid,
and
A.Richmond
(2006).
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways.
|
| |
Clin Cancer Res, 12,
950-960.
|
 |
|
|
|
|
 |
M.J.Schaaf,
L.Willetts,
B.P.Hayes,
B.Maschera,
E.Stylianou,
and
S.N.Farrow
(2006).
The relationship between intranuclear mobility of the NF-kappaB subunit p65 and its DNA binding affinity.
|
| |
J Biol Chem, 281,
22409-22420.
|
 |
|
|
|
|
 |
S.Bergqvist,
C.H.Croy,
M.Kjaergaard,
T.Huxford,
G.Ghosh,
and
E.A.Komives
(2006).
Thermodynamics reveal that helix four in the NLS of NF-kappaB p65 anchors IkappaBalpha, forming a very stable complex.
|
| |
J Mol Biol, 360,
421-434.
|
 |
|
|
|
|
 |
S.M.Truhlar,
C.H.Croy,
J.W.Torpey,
J.R.Koeppe,
and
E.A.Komives
(2006).
Solvent accessibility of protein surfaces by amide H/2H exchange MALDI-TOF mass spectrometry.
|
| |
J Am Soc Mass Spectrom, 17,
1490-1497.
|
 |
|
|
|
|
 |
S.M.Truhlar,
J.W.Torpey,
and
E.A.Komives
(2006).
Regions of IkappaBalpha that are critical for its inhibition of NF-kappaB.DNA interaction fold upon binding to NF-kappaB.
|
| |
Proc Natl Acad Sci U S A, 103,
18951-18956.
|
 |
|
|
|
|
 |
Y.Nam,
P.Sliz,
L.Song,
J.C.Aster,
and
S.C.Blacklow
(2006).
Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes.
|
| |
Cell, 124,
973-983.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Z.P.Wang,
S.X.Cai,
D.B.Liu,
X.Xu,
and
H.P.Liang
(2006).
Anti-inflammatory effects of a novel peptide designed to bind with NF-kappaB p50 subunit.
|
| |
Acta Pharmacol Sin, 27,
1474-1478.
|
 |
|
|
|
|
 |
E.Hertlein,
J.Wang,
K.J.Ladner,
N.Bakkar,
and
D.C.Guttridge
(2005).
RelA/p65 regulation of IkappaBbeta.
|
| |
Mol Cell Biol, 25,
4956-4968.
|
 |
|
|
|
|
 |
G.Qing,
Z.Qu,
and
G.Xiao
(2005).
Regulation of NF-kappa B2 p100 processing by its cis-acting domain.
|
| |
J Biol Chem, 280,
18-27.
|
 |
|
|
|
|
 |
H.Thoetkiattikul,
M.H.Beck,
and
M.R.Strand
(2005).
Inhibitor kappaB-like proteins from a polydnavirus inhibit NF-kappaB activation and suppress the insect immune response.
|
| |
Proc Natl Acad Sci U S A, 102,
11426-11431.
|
 |
|
|
|
|
 |
J.A.Kroemer,
and
B.A.Webb
(2005).
Ikappabeta-related vankyrin genes in the Campoletis sonorensis ichnovirus: temporal and tissue-specific patterns of expression in parasitized Heliothis virescens lepidopteran hosts.
|
| |
J Virol, 79,
7617-7628.
|
 |
|
|
|
|
 |
J.J.Babon,
S.Yao,
D.P.DeSouza,
C.F.Harrison,
L.J.Fabri,
E.Liepinsh,
S.D.Scrofani,
M.Baca,
and
R.S.Norton
(2005).
Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain.
|
| |
FEBS J, 272,
6120-6130.
|
 |
|
|
|
|
 |
J.Osborne,
A.Lake,
F.E.Alexander,
G.M.Taylor,
and
R.F.Jarrett
(2005).
Germline mutations and polymorphisms in the NFKBIA gene in Hodgkin lymphoma.
|
| |
Int J Cancer, 116,
646-651.
|
 |
|
|
|
|
 |
L.Opperman,
B.Hook,
M.DeFino,
D.S.Bernstein,
and
M.Wickens
(2005).
A single spacer nucleotide determines the specificities of two mRNA regulatory proteins.
|
| |
Nat Struct Mol Biol, 12,
945-951.
|
 |
|
|
|
|
 |
M.P.Lussier,
S.Cayouette,
P.K.Lepage,
C.L.Bernier,
N.Francoeur,
M.St-Hilaire,
M.Pinard,
and
G.Boulay
(2005).
MxA, a member of the dynamin superfamily, interacts with the ankyrin-like repeat domain of TRPC.
|
| |
J Biol Chem, 280,
19393-19400.
|
 |
|
|
|
|
 |
O.Y.Lubman,
R.Kopan,
G.Waksman,
and
S.Korolev
(2005).
The crystal structure of a partial mouse Notch-1 ankyrin domain: repeats 4 through 7 preserve an ankyrin fold.
|
| |
Protein Sci, 14,
1274-1281.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Fagerlund,
L.Kinnunen,
M.Köhler,
I.Julkunen,
and
K.Melén
(2005).
NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4.
|
| |
J Biol Chem, 280,
15942-15951.
|
 |
|
|
|
|
 |
Y.Kabe,
K.Ando,
S.Hirao,
M.Yoshida,
and
H.Handa
(2005).
Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus.
|
| |
Antioxid Redox Signal, 7,
395-403.
|
 |
|
|
|
|
 |
A.Chantôme,
A.Pance,
N.Gauthier,
D.Vandroux,
J.Chenu,
E.Solary,
J.F.Jeannin,
and
S.Reveneau
(2004).
Casein kinase II-mediated phosphorylation of NF-kappaB p65 subunit enhances inducible nitric-oxide synthase gene transcription in vivo.
|
| |
J Biol Chem, 279,
23953-23960.
|
 |
|
|
|
|
 |
C.H.Croy,
S.Bergqvist,
T.Huxford,
G.Ghosh,
and
E.A.Komives
(2004).
Biophysical characterization of the free IkappaBalpha ankyrin repeat domain in solution.
|
| |
Protein Sci, 13,
1767-1777.
|
 |
|
|
|
|
 |
G.Xiao,
A.Fong,
and
S.C.Sun
(2004).
Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation.
|
| |
J Biol Chem, 279,
30099-30105.
|
 |
|
|
|
|
 |
H.Pang,
M.Bartlam,
Q.Zeng,
H.Miyatake,
T.Hisano,
K.Miki,
L.L.Wong,
G.F.Gao,
and
Z.Rao
(2004).
Crystal structure of human pirin: an iron-binding nuclear protein and transcription cofactor.
|
| |
J Biol Chem, 279,
1491-1498.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.M.Verma
(2004).
Nuclear factor (NF)-kappaB proteins: therapeutic targets.
|
| |
Ann Rheum Dis, 63,
ii57-ii61.
|
 |
|
|
|
|
 |
L.K.Mosavi,
T.J.Cammett,
D.C.Desrosiers,
and
Z.Y.Peng
(2004).
The ankyrin repeat as molecular architecture for protein recognition.
|
| |
Protein Sci, 13,
1435-1448.
|
 |
|
|
|
|
 |
R.Ran,
A.Lu,
L.Zhang,
Y.Tang,
H.Zhu,
H.Xu,
Y.Feng,
C.Han,
G.Zhou,
A.C.Rigby,
and
F.R.Sharp
(2004).
Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappa B survival signaling.
|
| |
Genes Dev, 18,
1466-1481.
|
 |
|
|
|
|
 |
S.Krzywda,
A.M.Brzozowski,
H.Higashitsuji,
J.Fujita,
R.Welchman,
S.Dawson,
R.J.Mayer,
and
A.J.Wilkinson
(2004).
The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
|
| |
J Biol Chem, 279,
1541-1545.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Ito,
Y.Hozumi,
F.Sakane,
S.Saino-Saito,
H.Kanoh,
M.Aoyagi,
H.Kondo,
and
K.Goto
(2004).
Cloning and characterization of diacylglycerol kinase iota splice variants in rat brain.
|
| |
J Biol Chem, 279,
23317-23326.
|
 |
|
|
|
|
 |
X.Lu,
P.Farmer,
J.Rubin,
and
M.S.Nanes
(2004).
Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
|
| |
J Cell Biochem, 92,
833-848.
|
 |
|
|
|
|
 |
A.Kohl,
H.K.Binz,
P.Forrer,
M.T.Stumpp,
A.Plückthun,
and
M.G.Grütter
(2003).
Designed to be stable: crystal structure of a consensus ankyrin repeat protein.
|
| |
Proc Natl Acad Sci U S A, 100,
1700-1705.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Ryo,
F.Suizu,
Y.Yoshida,
K.Perrem,
Y.C.Liou,
G.Wulf,
R.Rottapel,
S.Yamaoka,
and
K.P.Lu
(2003).
Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA.
|
| |
Mol Cell, 12,
1413-1426.
|
 |
|
|
|
|
 |
E.Derudder,
E.Dejardin,
L.L.Pritchard,
D.R.Green,
M.Korner,
and
V.Baud
(2003).
RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100.
|
| |
J Biol Chem, 278,
23278-23284.
|
 |
|
|
|
|
 |
H.N.Arst,
and
M.A.Peñalva
(2003).
pH regulation in Aspergillus and parallels with higher eukaryotic regulatory systems.
|
| |
Trends Genet, 19,
224-231.
|
 |
|
|
|
|
 |
H.R.Mott,
D.Nietlispach,
L.J.Hopkins,
G.Mirey,
J.H.Camonis,
and
D.Owen
(2003).
Structure of the GTPase-binding domain of Sec5 and elucidation of its Ral binding site.
|
| |
J Biol Chem, 278,
17053-17059.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Li,
S.H.Joo,
and
M.D.Tsai
(2003).
An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
|
| |
Biochemistry, 42,
13476-13483.
|
 |
|
|
|
|
 |
K.S.Tang,
A.R.Fersht,
and
L.S.Itzhaki
(2003).
Sequential unfolding of ankyrin repeats in tumor suppressor p16.
|
| |
Structure, 11,
67-73.
|
 |
|
|
|
|
 |
L.Ganesh,
E.Burstein,
A.Guha-Niyogi,
M.K.Louder,
J.R.Mascola,
L.W.Klomp,
C.Wijmenga,
C.S.Duckett,
and
G.J.Nabel
(2003).
The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.
|
| |
Nature, 426,
853-857.
|
 |
|
|
|
|
 |
M.A.Pratt,
T.E.Bishop,
D.White,
G.Yasvinski,
M.Ménard,
M.Y.Niu,
and
R.Clarke
(2003).
Estrogen withdrawal-induced NF-kappaB activity and bcl-3 expression in breast cancer cells: roles in growth and hormone independence.
|
| |
Mol Cell Biol, 23,
6887-6900.
|
 |
|
|
|
|
 |
M.E.Zweifel,
D.J.Leahy,
F.M.Hughson,
and
D.Barrick
(2003).
Structure and stability of the ankyrin domain of the Drosophila Notch receptor.
|
| |
Protein Sci, 12,
2622-2632.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.J.Giffin,
J.C.Stroud,
D.L.Bates,
K.D.von Koenig,
J.Hardin,
and
L.Chen
(2003).
Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element.
|
| |
Nat Struct Biol, 10,
800-806.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Beinke,
J.Deka,
V.Lang,
M.P.Belich,
P.A.Walker,
S.Howell,
S.J.Smerdon,
S.J.Gamblin,
and
S.C.Ley
(2003).
NF-kappaB1 p105 negatively regulates TPL-2 MEK kinase activity.
|
| |
Mol Cell Biol, 23,
4739-4752.
|
 |
|
|
|
|
 |
S.Malek,
D.B.Huang,
T.Huxford,
S.Ghosh,
and
G.Ghosh
(2003).
X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex.
|
| |
J Biol Chem, 278,
23094-23100.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Saccani,
S.Pantano,
and
G.Natoli
(2003).
Modulation of NF-kappaB activity by exchange of dimers.
|
| |
Mol Cell, 11,
1563-1574.
|
 |
|
|
|
|
 |
Y.Nam,
A.P.Weng,
J.C.Aster,
and
S.C.Blacklow
(2003).
Structural requirements for assembly of the CSL.intracellular Notch1.Mastermind-like 1 transcriptional activation complex.
|
| |
J Biol Chem, 278,
21232-21239.
|
 |
|
|
|
|
 |
A.Birbach,
P.Gold,
B.R.Binder,
E.Hofer,
R.de Martin,
and
J.A.Schmid
(2002).
Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus.
|
| |
J Biol Chem, 277,
10842-10851.
|
 |
|
|
|
|
 |
A.Kanayama,
J.Inoue,
Y.Sugita-Konishi,
M.Shimizu,
and
Y.Miyamoto
(2002).
Oxidation of Ikappa Balpha at methionine 45 is one cause of taurine chloramine-induced inhibition of NF-kappa B activation.
|
| |
J Biol Chem, 277,
24049-24056.
|
 |
|
|
|
|
 |
B.Furia,
L.Deng,
K.Wu,
S.Baylor,
K.Kehn,
H.Li,
R.Donnelly,
T.Coleman,
and
F.Kashanchi
(2002).
Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins.
|
| |
J Biol Chem, 277,
4973-4980.
|
 |
|
|
|
|
 |
L.F.Chen,
Y.Mu,
and
W.C.Greene
(2002).
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.
|
| |
EMBO J, 21,
6539-6548.
|
 |
|
|
|
|
 |
L.M.Budde,
C.Wu,
C.Tilman,
I.Douglas,
and
S.Ghosh
(2002).
Regulation of IkappaBbeta expression in testis.
|
| |
Mol Biol Cell, 13,
4179-4194.
|
 |
|
|
|
|
 |
M.Davis,
A.Hatzubai,
J.S.Andersen,
E.Ben-Shushan,
G.Z.Fisher,
A.Yaron,
A.Bauskin,
F.Mercurio,
M.Mann,
and
Y.Ben-Neriah
(2002).
Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.
|
| |
Genes Dev, 16,
439-451.
|
 |
|
|
|
|
 |
P.Knuefermann,
P.Chen,
A.Misra,
S.P.Shi,
M.Abdellatif,
and
N.Sivasubramanian
(2002).
Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers.
|
| |
J Biol Chem, 277,
23888-23897.
|
 |
|
|
|
|
 |
P.Michaely,
D.R.Tomchick,
M.Machius,
and
R.G.Anderson
(2002).
Crystal structure of a 12 ANK repeat stack from human ankyrinR.
|
| |
EMBO J, 21,
6387-6396.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Q.Li,
and
I.M.Verma
(2002).
NF-kappaB regulation in the immune system.
|
| |
Nat Rev Immunol, 2,
725-734.
|
 |
|
|
|
|
 |
S.Ghosh,
and
M.Karin
(2002).
Missing pieces in the NF-kappaB puzzle.
|
| |
Cell, 109,
S81-S96.
|
 |
|
|
|
|
 |
T.C.Mitchell,
B.S.Thompson,
J.O.Trent,
and
C.R.Casella
(2002).
A short domain within Bcl-3 is responsible for its lymphocyte survival activity.
|
| |
Ann N Y Acad Sci, 975,
132-147.
|
 |
|
|
|
|
 |
T.Nishi,
N.Shimizu,
M.Hiramoto,
I.Sato,
Y.Yamaguchi,
M.Hasegawa,
S.Aizawa,
H.Tanaka,
K.Kataoka,
H.Watanabe,
and
H.Handa
(2002).
Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo.
|
| |
J Biol Chem, 277,
44548-44556.
|
 |
|
|
|
|
 |
C.Lee,
M.P.Schwartz,
S.Prakash,
M.Iwakura,
and
A.Matouschek
(2001).
ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal.
|
| |
Mol Cell, 7,
627-637.
|
 |
|
|
|
|
 |
D.Joyce,
C.Albanese,
J.Steer,
M.Fu,
B.Bouzahzah,
and
R.G.Pestell
(2001).
NF-kappaB and cell-cycle regulation: the cyclin connection.
|
| |
Cytokine Growth Factor Rev, 12,
73-90.
|
 |
|
|
|
|
 |
F.Michel,
M.Soler-Lopez,
C.Petosa,
P.Cramer,
U.Siebenlist,
and
C.W.Müller
(2001).
Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.
|
| |
EMBO J, 20,
6180-6190.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Poulsen,
J.Nilsson,
C.K.Damgaard,
J.Egebjerg,
and
J.Kjems
(2001).
CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain.
|
| |
Mol Cell Biol, 21,
7862-7871.
|
 |
|
|
|
|
 |
J.M.Mingot,
E.A.Espeso,
E.Díez,
and
M.A.Peñalva
(2001).
Ambient pH signaling regulates nuclear localization of the Aspergillus nidulans PacC transcription factor.
|
| |
Mol Cell Biol, 21,
1688-1699.
|
 |
|
|
|
|
 |
K.Y.Moon,
K.S.Ahn,
J.Lee,
and
Y.S.Kim
(2001).
Kojic acid, a potential inhibitor of NF-kappaB activation in transfectant human HaCaT and SCC-13 cells.
|
| |
Arch Pharm Res, 24,
307-311.
|
 |
|
|
|
|
 |
T.A.Edwards,
S.E.Pyle,
R.P.Wharton,
and
A.K.Aggarwal
(2001).
Structure of Pumilio reveals similarity between RNA and peptide binding motifs.
|
| |
Cell, 105,
281-289.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.T.Huang,
and
S.Miyamoto
(2001).
Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha.
|
| |
Mol Cell Biol, 21,
4737-4747.
|
 |
|
|
|
|
 |
W.F.Tam,
W.Wang,
and
R.Sen
(2001).
Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes.
|
| |
Mol Cell Biol, 21,
4837-4846.
|
 |
|
|
|
|
 |
A.M.DeSandro,
U.M.Nagarajan,
and
J.M.Boss
(2000).
Associations and interactions between bare lymphocyte syndrome factors.
|
| |
Mol Cell Biol, 20,
6587-6599.
|
 |
|
|
|
|
 |
B.Jungnickel,
A.Staratschek-Jox,
A.Bräuninger,
T.Spieker,
J.Wolf,
V.Diehl,
M.L.Hansmann,
K.Rajewsky,
and
R.Küppers
(2000).
Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma.
|
| |
J Exp Med, 191,
395-402.
|
 |
|
|
|
|
 |
D.A.Jans,
C.Y.Xiao,
and
M.H.Lam
(2000).
Nuclear targeting signal recognition: a key control point in nuclear transport?
|
| |
Bioessays, 22,
532-544.
|
 |
|
|
|
|
 |
D.H.Lum,
P.E.Kuwabara,
D.Zarkower,
and
A.M.Spence
(2000).
Direct protein-protein interaction between the intracellular domain of TRA-2 and the transcription factor TRA-1A modulates feminizing activity in C. elegans.
|
| |
Genes Dev, 14,
3153-3165.
|
 |
|
|
|
|
 |
D.J.Begun,
and
P.Whitley
(2000).
Adaptive evolution of relish, a Drosophila NF-kappaB/IkappaB protein.
|
| |
Genetics, 154,
1231-1238.
|
 |
|
|
|
|
 |
E.A.Drier,
S.Govind,
and
R.Steward
(2000).
Cactus-independent regulation of Dorsal nuclear import by the ventral signal.
|
| |
Curr Biol, 10,
23-26.
|
 |
|
|
|
|
 |
M.Karin,
and
M.Delhase
(2000).
The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.
|
| |
Semin Immunol, 12,
85-98.
|
 |
|
|
|
|
 |
M.Karin,
and
Y.Ben-Neriah
(2000).
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.
|
| |
Annu Rev Immunol, 18,
621-663.
|
 |
|
|
|
|
 |
S.P.Hehner,
T.G.Hofmann,
A.Ushmorov,
O.Dienz,
I.Wing-Lan Leung,
N.Lassam,
C.Scheidereit,
W.Dröge,
and
M.L.Schmitz
(2000).
Mixed-lineage kinase 3 delivers CD3/CD28-derived signals into the IkappaB kinase complex.
|
| |
Mol Cell Biol, 20,
2556-2568.
|
 |
|
|
|
|
 |
S.Sachdev,
S.Bagchi,
D.D.Zhang,
A.C.Mings,
and
M.Hannink
(2000).
Nuclear import of IkappaBalpha is accomplished by a ran-independent transport pathway.
|
| |
Mol Cell Biol, 20,
1571-1582.
|
 |
|
|
|
|
 |
T.T.Huang,
N.Kudo,
M.Yoshida,
and
S.Miyamoto
(2000).
A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.
|
| |
Proc Natl Acad Sci U S A, 97,
1014-1019.
|
 |
|
|
|
|
 |
W.Vanden Berghe,
L.Vermeulen,
G.De Wilde,
K.De Bosscher,
E.Boone,
and
G.Haegeman
(2000).
Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6.
|
| |
Biochem Pharmacol, 60,
1185-1195.
|
 |
|
|
|
|
 |
Y.M.Janssen-Heininger,
M.E.Poynter,
and
P.A.Baeuerle
(2000).
Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB.
|
| |
Free Radic Biol Med, 28,
1317-1327.
|
 |
|
|
|
|
 |
A.Kaffman,
and
E.K.O'Shea
(1999).
Regulation of nuclear localization: a key to a door.
|
| |
Annu Rev Cell Dev Biol, 15,
291-339.
|
 |
|
|
|
|
 |
B.Kaltschmidt,
T.Sparna,
and
C.Kaltschmidt
(1999).
Activation of NF-kappa B by reactive oxygen intermediates in the nervous system.
|
| |
Antioxid Redox Signal, 1,
129-144.
|
 |
|
|
|
|
 |
C.DeLuca,
H.Kwon,
R.Lin,
M.Wainberg,
and
J.Hiscott
(1999).
NF-kappaB activation and HIV-1 induced apoptosis.
|
| |
Cytokine Growth Factor Rev, 10,
235-253.
|
 |
|
|
|
|
 |
E.W.Harhaj,
and
S.C.Sun
(1999).
Regulation of RelA subcellular localization by a putative nuclear export signal and p50.
|
| |
Mol Cell Biol, 19,
7088-7095.
|
 |
|
|
|
|
 |
K.Rittinger,
J.Budman,
J.Xu,
S.Volinia,
L.C.Cantley,
S.J.Smerdon,
S.J.Gamblin,
and
M.B.Yaffe
(1999).
Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding.
|
| |
Mol Cell, 4,
153-166.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Delhase,
and
M.Karin
(1999).
The I kappa B kinase: a master regulator of NF-kappa B, innate immunity, and epidermal differentiation.
|
| |
Cold Spring Harb Symp Quant Biol, 64,
491-503.
|
 |
|
|
|
|
 |
M.Karin
(1999).
The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.
|
| |
J Biol Chem, 274,
27339-27342.
|
 |
|
|
|
|
 |
M.R.Groves,
and
D.Barford
(1999).
Topological characteristics of helical repeat proteins.
|
| |
Curr Opin Struct Biol, 9,
383-389.
|
 |
|
|
|
|
 |
P.Cramer,
and
C.W.Müller
(1999).
A firm hand on NFkappaB: structures of the IkappaBalpha-NFkappaB complex.
|
| |
Structure, 7,
R1-R6.
|
 |
|
|
|
|
 |
R.Weil,
H.Sirma,
C.Giannini,
D.Kremsdorf,
C.Bessia,
C.Dargemont,
C.Bréchot,
and
A.Israël
(1999).
Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha.
|
| |
Mol Cell Biol, 19,
6345-6354.
|
 |
|
|
|
|
 |
R.de Martin,
J.A.Schmid,
and
R.Hofer-Warbinek
(1999).
The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis.
|
| |
Mutat Res, 437,
231-243.
|
 |
|
|
|
|
 |
S.D.Shumway,
M.Maki,
and
S.Miyamoto
(1999).
The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain.
|
| |
J Biol Chem, 274,
30874-30881.
|
 |
|
|
|
|
 |
S.G.Sedgwick,
and
S.J.Smerdon
(1999).
The ankyrin repeat: a diversity of interactions on a common structural framework.
|
| |
Trends Biochem Sci, 24,
311-316.
|
 |
|
|
|
|
 |
T.Huxford,
S.Malek,
and
G.Ghosh
(1999).
Structure and mechanism in NF-kappa B/I kappa B signaling.
|
| |
Cold Spring Harb Symp Quant Biol, 64,
533-540.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |